• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Wondr Health Expands Weight Loss Program with Support for GLP-1 Users

by Fred Pennic 11/20/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Wondr Health, a leader in virtual metabolic health programs, has announced the expansion of its weight and obesity care solution, Wondr Plus. 

– The enhancement provides comprehensive lifestyle support and nutrition counseling for employees using GLP-1 weight-loss medications, addressing the challenges of medication adherence and side effects.

Addressing the Need for GLP-1 Support

While GLP-1 medications have shown promising results for weight loss, discontinuation rates remain high. Many individuals struggle with cost, side effects, and ineffective prescribing, leading to treatment cessation and potential health risks. Wondr Plus aims to mitigate these challenges by offering personalized support and guidance to optimize outcomes and promote sustainable weight loss.

Comprehensive Support for GLP-1 Users

Wondr Plus combines human and digital touchpoints to provide a comprehensive support system for employees using GLP-1 medications:

  • Personalized Lifestyle Support: Access to registered dietitians and certified health coaches for 1:1 nutrition counseling, guidance, and accountability.
  • Digital Content: Tailored digital resources focused on medication adherence, nutrition, healthy eating, exercise, and emotional well-being.
  • Condition-Specific Tracks: Preventive and therapeutic interventions for common metabolic conditions like diabetes and musculoskeletal issues.

With the rise of GLP-1 medications and the increasing prevalence of metabolic health conditions, employers are seeking effective solutions to support their workforce. Wondr Health’s full-spectrum approach offers a scalable and adaptable solution that strengthens employee benefit plans and helps contain healthcare costs.

“It’s no secret GLP-1s are highly effective for weight loss—that’s what is driving demand and demand is increasing access,” said Tim Church, MD, MPH, PHD, Chief Medical Officer, Wondr Health. “Whether they are getting medications through their primary care physician or another direct channel, people need personalized, expert obesity care and accountability to optimize and sustain health and quality of life outcomes.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: GLP-1

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |